Four dead, 29 in hospital after London attacks — policeWorld March 23, 11:36
Russia ready to discuss further reduction of nuclear capacities — LavrovRussian Politics & Diplomacy March 23, 10:51
Russia’s FSB cuts off weapons supplies from US via postal servicesRussian Politics & Diplomacy March 23, 10:18
Russian singer barred from Eurovision believes she still has chancesSociety & Culture March 23, 8:41
Chain of explosions reported from ammunition depot in northeastern UkraineWorld March 23, 8:15
Number of deaths in London terror attack rises to fourWorld March 23, 4:46
Putin proposes extending term of Russia's Central Bank chiefBusiness & Economy March 22, 21:49
Mayor says investigation into London attack is underwayWorld March 22, 21:16
Ukrainian radicals urge Poroshenko to nationalize Russian banks’ subsidiariesBusiness & Economy March 22, 20:51
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.